Prescribing JAKAVI (ruxolitinib) for MF
Prescribing JAKAVI (ruxolitinib) for MF
JAKAVI is recommended for patients with MF with symptomatic splenomegaly and/or MF-...
Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Hematologic ReactionsHematologic reactions are expected and manageable 1 ...
Entresto® (sacubitril/valsartan)
Indication Heart Failure Entresto® is indicated to reduce the risk of cardiovascular death and hospitalization for heart failure in adult patients with chronic heart failure. Benefits are most clearly evident in patients with left ventricular ejection...Clinical Resources
Access hypertension clinical trials information and download other useful resources for your practice
...
When to use JAKAVI (ruxolitinib)
When to use JAKAVI (ruxolitinib)Use JAKAVI as soon as patients are eligible to bring the most benefit to their lives 1-4 ...
Non Hematologic Reactions
JAKAVI (ruxolitinib) safety profile – Non Hematologic ReactionsWell-characterized and manageable...
About Diovan®
Diovan ® (valsartan) is an orally active, potent and specific angiotensin receptor blocker (ARB). It acts selectively on the AT 1 receptor subtype, which is responsible for the known actions of angiotensin II (...
×
Ask Speakers
×